(Nasdaq: SRLS)($13.L.C. As an
independent, employee-owned firm , our philosophy is to serve our clients'
interests first and foremost.
William Blair + Company , L.williamblair.com.

cameron reunited

"We believe SeraCare represents a promising small-cap life sciences firm
that should generate midteens or higher revenue and earnings growth over at
least the next three years," Gibbons said. Since 1935, we have been
committed to helping clients achieve their financial objectives. (Nasdaq: PHYX), entitled, "The Shape of
Things to Come".

CONTACT:
Scimitar Equity Research, Inc.

separated pursuit

was a manager or co-manager of a public
offering of equity securities within the prior 12 months.C. This review is available at our website:
http://www.

bye heather

scimitarequity . Any opinions
expressed are statements of our own judgment as of the date of publication and
are subject to change without notice. Please read all our important
disclosures.
Henry W.

matt gone

( http://www.C.

hell matt

com ) is a
Chicago-based investment firm offering investment banking, asset management ,
equity research, institutional and private brokerage, and private capital to
individual, institutional , and issuing clients.

expressing minibites

McCusker
Director of Research
phone: (617) 236-6396
fax: (617) 236-6397
e-mail: hwm@scimitarequity.com

lovey matt

75 per share in fiscal 2006.

gone reunited

William Blair + Company Initiates Coverage of SeraCare Life Sciences Inc. With Outperform Rating

williamblair . We place a high value on the enduring nature of
our client relationships, the quality of our products and services, and the
continuity and integrity of our people.

shares relationship

has received compensation for investment
banking services from the company within the past 12 months, or expects to
receive or intends to seek compensation for investment banking services in the
next 3 months. (Scimitar) provides sponsored equity
research of the health sciences industry for the institutional and investment
communities .

poof shares

L. Investors are advised that this analysis
and review is issued solely for informational purposes and is not to be
construed as an offer to sell or the solicitation of an offer to buy. Scimitar
was paid for preparing this review.

chronicling separated

L. BOSTON, Scimitar Equity Research, Inc.

hell chronicling

C.
Scimitar Equity Research, Inc.

cameron morrissey

"In our view, the company can
further solidify these growth prospects through accretive acquisitions in the
faster-growing segments of life sciences, such as stem cells and biologics
manufacturing .
William Blair + Company, L.

heather vacations

hell morrissey

issues a review of Physiometrix, Inc.

bennett vacations

Analyst Winton Gibbons estimated that the company would earn $0."

William Blair + Company, L.com/pages/news_story .

heather morrissey

53), an emerging company focused on developing biological
supplies and services to the life sciences , clinical diagnostics, and
biopharmaceuticals market, with an Outperform rating and company profile of
Aggressive Growth.65 per
share in fiscal 2005 and $0. William Blair + Company has offices
in Chicago, Hartford, London, San Francisco, Tokyo, Vaduz, and Zurich.
William Blair + Company , L. is a market maker in the security of this
company and may have a long or short position. We certify that all the views expressed in this review,
accurately reflect our personal views about PHYX (NASDAQ) and its or their
securities. No part of our compensation was, is, or will be, directly or
indirectly, related to the specific recommendations or views contained in this
review and we will not have any investment banking relationships or personal
investment in any sponsored company .

reunited expressing

lovey reunited

asp?uid=858

Additional information is available upon request.

minibites relationship

morrissey expressing

For important disclosures and information regarding the firm's rating
system, valuation methods and potential conflicts of interest, please visit:
http://www.

shares bye

chronicling gone

pursuit chronicling

CHICAGO, William Blair + Company today announced
that it initiated research coverage of SeraCare Life Sciences, Inc.

Scimitar Equity Research Issues Review of Physiometrix Inc.

This analysis and review does not have
regard to the specific investment objectives, financial situation and the
information contained herein is based on sources that we believe to be
reliable but is not guaranteed by us as being accurate and does not purport to
be a complete statement or summary of the available data.